OPINION

Big pharma jumps back into flu business

IBTimes Logo
A dearth of new products, new technologies and fresh commitments by governments scrambling to protect their populations from pandemic threats have lured U.S. drugmakers back into the flu vaccine business.
More news
IBTimes Logo

Mid-Day Minute - Sept 15

Worst is Probably Over: Bernanke; Banks to Remain in Bailout Web for Now; Analysts Still Plague by Lehman Bust

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.